ACTRN12616000663459已完成1 期
A single dose, randomized, blinded, 2 way crossover pilot pharmacokinetic study of 1 test formulation of isotretinoin capsule against the innovator isotretinoin capsule conducted under fasting conditions in healthy male volunteers
适应症
试验速览
- 阶段
- 1 期
- 状态
- 已完成
- 入组人数
- 16
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
- 分配方式
- Randomised controlled trial
- 主要目的
- Treatment
- 盲法
- Blinded (masking used)
入排标准
- 年龄范围
- 18 Years 至 55 Years（—）
- 性别
- Male
入选标准
- •Healthy males
- •Aged between 18 and 55 years
- •Non-smoker
- •BMI greater than or equal to 19 and less than 30 inclusive
- •Normal, healthy individuals as determined by medical history, physical examination, ECG, blood pressure and laboratory tests
- •Drug free as determined by urine drug testing
- •Able to comply with the study restrictions
- •Able to provide written information consent
排除标准
- •Concomitant drug therapy of any kind
- •History of depression or other mental illness, or a history of epilepsy or seizures
- •History of conditions that might interfere with the absorption, distribution, metabolism or excretion of the drug
- •History of alcohol or drug abuse or dependency
- •Sensitivities to Vitamin A or food such as liver
- •Participation in a drug study within 60 days of the start of the study or undertaking to donate blood within 60 days after the completion of the study
- •Sensitivities to isotretinoin, its excipients or any other retinoids
- •Individuals for whom the Clinical Investigator believes, for any reason, that participation would not be an acceptable risk
研究者
相似试验
进行中（未招募）
1 期
Study in Subjects with Asthma to Compare the Bronchodilatoric Effects of Salmeterol (at two different doses) and Fluticasone Propionate when Taken Via a Novel Inhaler Device (PulmoJet®) Compared to the Seretide Diskus® InhalerEUCTR2014-005047-40-BGSanofi-Aventis AG120
进行中（未招募）
1 期
Study in Subjects with Asthma to Compare the Bronchodilatoric Effects of Salmeterol (at two different doses) and Fluticasone Propionate when Taken Via a Novel Inhaler Device (PulmoJet®) Compared to the Seretide Diskus® InhalerMild to moderate asthmaMedDRA version: 17.1Level: LLTClassification code 10003565Term: AsthmaticSystem Organ Class: 100000004855EUCTR2014-005047-40-DESanofi-Aventis AG120
进行中（未招募）
1 期
Study in Subjects with Asthma to Compare the Bronchodilatoric Effects of Salmeterol (at two different doses) and Fluticasone Propionate when Taken Via a Novel Inhaler Device (PulmoJet®) Compared to the Seretide Diskus® InhalerEUCTR2014-005047-40-GBSanofi-Aventis AG240
已完成
1 期
Comparative assessment in healthy male volunteers under fasting conditions of the absorption and pharmacokinetics of 3 generic formulations of isotretinoin capsules against the innovator isotretinoin capsule in a pilot studyACTRN12615001083583Zenith Technology Corp Ltd15
进行中（未招募）
不适用
A single dose, randomized, double blind, double dummy, placebo controlled, three-period crossover clinical study, comparing the onset of relief from methacholine induced bronchoconstriction with fixed combination beclomethasone dipropionate 100 µg plus formoterol fumarate 6 µg/actuation pMDI with HFA-134a propellant (Foster) versus standard salbutamol pMDI 100 µg/actuation (Ventolin Evohaler) therapy in asthmatic patients. - MART 1 Maintenance And Reliever TherapyAshtmaMedDRA version: 9.1Level: LLTClassification code 10003553Term: AsthmaEUCTR2008-000905-12-ITCHIESI